Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue. [electronic resource] by
- Stroh, M
- Carlile, D J
- Li, C-C
- Wagg, J
- Ribba, B
- Ramanujan, S
- Jin, J
- Xu, J
- Charoin, J-E
- Xhu, Z-X
- Morcos, P N
- Davis, J D
- Phipps, A
Producer: 20151009
In:
CPT: pharmacometrics & systems pharmacology vol. 4
Availability: No items available.
|
|
15.
|
SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer. [electronic resource] by
- Soria, J-C
- Fülöp, A
- Maciel, C
- Fischer, J R
- Girotto, G
- Lago, S
- Smit, E
- Ostoros, G
- Eberhardt, W E E
- Lishkovska, P
- Lovick, S
- Mariani, G
- McKeown, A
- Kilgour, E
- Smith, P
- Bowen, K
- Kohlmann, A
- Carlile, D J
- Jänne, P A
Producer: 20180502
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|